Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.079 AUD | +1.28% |
|
+5.33% | +14.49% |
10/07 | Neurotech International Validates Efficacy of Cannabis Therapy in Autism Trial; Shares Rise 3% | MT |
09/07 | Neurotech International Files for US Orphan Drug Designation for Neurological Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+14.49% | 5.45Cr | |
+25.83% | 4.66TCr | |
+45.38% | 4.17TCr | |
+0.69% | 4.12TCr | |
+30.52% | 3.24TCr | |
+22.30% | 2.82TCr | |
-6.35% | 2.81TCr | |
+49.25% | 1.45TCr | |
+49.18% | 1.37TCr | |
+3.45% | 1.22TCr |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- Neurotech International Validates Efficacy of Cannabis Therapy in Autism Trial; Shares Rise 3%